Laboratory Monitoring for Patients on Angiotensin-Converting Enzyme Inhibitors or Angiotensin

Multiple Choice

Laboratory monitoring for patients on angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers should include:

A) White blood cell counts with the drug dosage increased for elevations above 10,000 feet
B) Liver function tests with the drug dosage stopped for alanine aminotransferase values twice that of normal
C) Serum creatinine levels with the drug dosage reduced for values greater than 2.5 mg/dL
D) Serum glucose levels with the drug dosage increased for levels greater than 120 mg/dL